Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Just Launched! RxAdvanced hospital competency training for pharmacists and PTU Elite: Immunizations pharmacy technician training program. Get a quote.

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

  • Diabetes (347)
  • Endocrinology (9)
  • Hyperglycemia (28)
  • Hypoglycemia (15)
  • Other (16)
  • Resources (162)
    • Charts (36)
    • Guidelines (24)
    • Letters (3)
    • Natural Medicines / Supplements (2)
    • Patient Education (10)
    • PL Voices (113)
    • Quality Measures (29)
  • Thyroid Disorders (24)
136 - 150 of 162 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (ADA) June 2012
Commentary: Treating Microalbuminuria April 2012
PL Voices: How to Manage Microalbuminuria in Patients with Diabetes April 2012
PL Voices: New Once WEEKLY Exenatide (Bydureon) March 2012
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Guideline: Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy (2011) June 2011
Chart: Comparison of Common Meds for Diabetic Neuropathy June 2011
Commentary: New Drug: Tradjenta (Linagliptin) June 2011
Guideline: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) June 2011
Patient Education: Blood Pressure Medications and You February 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) August 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved